本页面由Tiger Trade Technology Pte. Ltd.提供服务

Crescent Biopharma Inc

12.91
-1.5500-10.72%
盘后:12.910.00000.00%19:30 EDT
成交量:19.71万
成交额:263.27万
市值:4.80亿
市盈率:-1.74
高:14.67
开:14.46
低:12.85
收:14.46
52周最高:27.41
52周最低:8.72
股本:3,714.39万
流通股本:1,595.35万
量比:0.42
换手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-7.4105
每股收益(LYR):-12.8150
净资产收益率:-160.75%
总资产收益率:-69.15%
市净率:6.61
市盈率(LYR):-1.01

数据加载中...

2022/05/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/02

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/05

重要事件披露

8-K - Current report
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/16

重要事件披露

8-K - Current report
2022/03/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/25

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report